Henry Schein Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Henry Schein wird ein jährliches Gewinn- und Umsatzwachstum von 24.7% bzw. 5.8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 20.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 14.9% betragen.
Wichtige Informationen
24.2%
Wachstumsrate der Gewinne
19.2%
EPS-Wachstumsrate
Healthcare Gewinnwachstum | 19.3% |
Wachstumsrate der Einnahmen | 4.9% |
Zukünftige Eigenkapitalrendite | 14.7% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 20 Sep 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Henry Schein (NASDAQ:HSIC) Will Be Hoping To Turn Its Returns On Capital Around
Aug 20Is It Time To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?
Aug 02Market Participants Recognise Henry Schein, Inc.'s (NASDAQ:HSIC) Earnings
Jun 27Henry Schein: Acquisition Strategy Isn't Pulling Its Economic Weight
May 23Here's Why Henry Schein (NASDAQ:HSIC) Has A Meaningful Debt Burden
May 22Is It Too Late To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?
May 02There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital
Apr 14Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward
Feb 28Is Henry Schein (NASDAQ:HSIC) A Risky Investment?
Oct 11Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?
Sep 23Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?
Aug 21Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively
Aug 01These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well
Jul 09At US$74.94, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely?
Jun 09Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 36%?
May 21Henry Schein (NASDAQ:HSIC) Hasn't Managed To Accelerate Its Returns
May 01Here's Why Henry Schein (NASDAQ:HSIC) Can Manage Its Debt Responsibly
Apr 10Estimating The Intrinsic Value Of Henry Schein, Inc. (NASDAQ:HSIC)
Feb 15Returns On Capital At Henry Schein (NASDAQ:HSIC) Have Stalled
Jan 28These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well
Jan 10Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?
Dec 11Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 43% Undervaluation?
Nov 04Buy Henry Schein To Receive 'Resiliency Premium' In Equity Portfolios
Aug 25Henry Schein announces $400M increase to stock buyback plan
Aug 18If EPS Growth Is Important To You, Henry Schein (NASDAQ:HSIC) Presents An Opportunity
Aug 09Henry Schein Q2 2022 Earnings Preview
Aug 01Be Wary Of Henry Schein (NASDAQ:HSIC) And Its Returns On Capital
Jul 04Does Henry Schein (NASDAQ:HSIC) Have A Healthy Balance Sheet?
Jun 14Henry Schein: Neutral On Valuation, Covid-19 Sales Slowdown
Jun 09Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2026 | 14,103 | 658 | 800 | 1,062 | 10 |
12/31/2025 | 13,526 | 573 | 725 | 952 | 13 |
12/31/2024 | 12,939 | 447 | 667 | 859 | 13 |
6/29/2024 | 12,487 | 352 | 495 | 692 | N/A |
3/30/2024 | 12,451 | 388 | 473 | 670 | N/A |
12/30/2023 | 12,339 | 416 | 313 | 500 | N/A |
9/30/2023 | 12,693 | 445 | 597 | 786 | N/A |
7/1/2023 | 12,598 | 458 | 480 | 653 | N/A |
4/1/2023 | 12,528 | 478 | 387 | 536 | N/A |
12/31/2022 | 12,647 | 538 | 474 | 602 | N/A |
9/24/2022 | 12,607 | 638 | 528 | 625 | N/A |
6/25/2022 | 12,718 | 650 | 648 | 738 | N/A |
3/26/2022 | 12,655 | 646 | 656 | 740 | N/A |
12/25/2021 | 12,401 | 631 | 598 | 710 | N/A |
9/25/2021 | 12,236 | 626 | 723 | 783 | N/A |
6/26/2021 | 11,898 | 606 | 783 | 833 | N/A |
3/27/2021 | 10,615 | 438 | 544 | 583 | N/A |
12/26/2020 | 10,119 | 403 | 550 | 599 | N/A |
9/26/2020 | 9,622 | 591 | 477 | 542 | N/A |
6/27/2020 | 9,291 | 585 | 436 | 512 | N/A |
3/28/2020 | 10,054 | 713 | 683 | 766 | N/A |
12/28/2019 | 9,986 | 701 | 578 | 654 | N/A |
9/28/2019 | 9,789 | 488 | 585 | 655 | N/A |
6/29/2019 | 9,636 | 444 | 526 | 597 | N/A |
3/30/2019 | 9,504 | 438 | 648 | 722 | N/A |
12/29/2018 | 9,418 | 431 | 613 | 685 | N/A |
9/29/2018 | 10,263 | 304 | 553 | 629 | N/A |
6/30/2018 | 11,069 | 352 | 511 | 586 | N/A |
3/31/2018 | 11,812 | 377 | N/A | 527 | N/A |
12/30/2017 | 8,883 | 293 | N/A | 546 | N/A |
9/30/2017 | 12,264 | 554 | N/A | 572 | N/A |
7/1/2017 | 11,968 | 550 | N/A | 619 | N/A |
4/1/2017 | 11,782 | 534 | N/A | 668 | N/A |
12/31/2016 | 11,572 | 507 | N/A | 643 | N/A |
9/24/2016 | 11,302 | 498 | N/A | 676 | N/A |
6/25/2016 | 11,122 | 492 | N/A | 605 | N/A |
3/26/2016 | 10,879 | 489 | N/A | 536 | N/A |
12/26/2015 | 10,630 | 479 | N/A | 616 | N/A |
9/26/2015 | 10,481 | 482 | N/A | 563 | N/A |
6/27/2015 | 10,419 | 469 | N/A | 630 | N/A |
3/28/2015 | 10,405 | 467 | N/A | 621 | N/A |
12/27/2014 | 10,371 | 466 | N/A | 593 | N/A |
9/27/2014 | 10,196 | 457 | N/A | 593 | N/A |
6/28/2014 | 9,921 | 450 | N/A | 571 | N/A |
3/29/2014 | 9,697 | 442 | N/A | 647 | N/A |
12/28/2013 | 9,561 | 432 | N/A | 664 | N/A |
9/28/2013 | 9,443 | 420 | N/A | 589 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: HSICDas prognostizierte Gewinnwachstum (24.7% pro Jahr) liegt über der Sparquote (2.4%).
Ertrag vs. Markt: HSICDie Erträge des Unternehmens (24.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (14.8% pro Jahr).
Hohe Wachstumserträge: HSICEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: HSICDie Einnahmen des Unternehmens (5.8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).
Hohe Wachstumseinnahmen: HSICDie Einnahmen des Unternehmens (5.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: HSICDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (14.9%).